News & Updates

Intestinal ultrasound could be a simple, effective, and noninvasive tool for detecting the recurrence of Crohn’s disease (CD) after surgery, according to an expert at CCC 2022.

Higher induction regimens are not superior to standard induction regimens for the use of adalimumab in patients with Crohn’s disease (CD), reports a new study. Similarly, clinically-adjusted and therapeutic drug monitoring maintenance strategies yield similar efficacies.

Use of saffron (Crocus Sativus) as an alternative or supplemental treatment for ulcerative colitis (UC) leads to improvements in clinical response for faecal calprotectin and in partial Mayo scores, according to a study presented at the recently concluded 2022 Crohn’s & Colitis Congress.

The presence of appendicolith is tied to an almost twofold risk of requiring an appendectomy within 30 days in patients who initially received antibiotic therapy for acute uncomplicated appendicitis, according to an analysis of the CODA* study from the US.

Using the probiotic Escherichia coli Nissle 1917 (EcN) as add-on therapy for patients with mild-to-moderate ulcerative colitis (UC) helps induce disease remission and preserve quality of life (QoL) in these patients, according to studies presented at CCC 2022.